Sana Biotechnology (SANA) Long-Term Investments (2020 - 2023)

Sana Biotechnology (SANA) has 4 years of Long-Term Investments data on file, last reported at $5.8 million in Q1 2023.

• For the quarter ending Q1 2023, Long-Term Investments fell 95.98% year-over-year to $5.8 million; the trailing twelve-month figure through Mar 2023 stood at $5.8 million (down 95.98% YoY), and the FY2022 full-year result was $10.1 million, down 94.87% from the prior year.
• Long-Term Investments retreated to $5.8 million in Q1 2023, from $10.1 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $262.4 million in Q3 2021 to a low of $5.8 million in Q1 2023.
• A 4-year average of $87.3 million and a median of $55.8 million in 2020 frame the typical range for Long-Term Investments.
• Across the five-year window, Long-Term Investments jumped 570.52% in 2022 and sank 95.98% in 2023, its largest moves.
• Tracing SANA's Long-Term Investments over 4 years: stood at $33.7 million in 2020, then jumped by 480.72% to $195.9 million in 2021, then sank by 94.87% to $10.1 million in 2022, then tumbled by 42.05% to $5.8 million in 2023.
• Business Quant data shows SANA's Long-Term Investments at $5.8 million in Q1 2023, $10.1 million in Q4 2022, and $25.8 million in Q3 2022.